Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Biotechnology: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global landscape of biotechnology is witnessing an unprecedented surge with market size reaching profound milestones. As industries navigate the post-pandemic era, the latest research publication added to our comprehensive collection of reports indicates a significant upward trend, with the Biotechnology market expected to achieve a valuation of $1.1 trillion by 2030. An impressive Compound Annual Growth Rate (CAGR) of 8.5% from 2022 to 2030 speaks volumes about the sector’s robust and resilient growth.
Notably, the DNA Sequencing Market emerges as a standout segment, contributing sizably to the overall industry with a forecasted 8.7% CAGR, leading towards a $33.5 billion milestone by the end of the decade. Alongside DNA Sequencing, the Fermentation segment is also gaining momentum with an expected 8.2% CAGR, marking its vital presence in the biotechnology sphere.
Bearing its economic prowess, the United States is currently estimated at $150.2 billion, setting a strong foundation for biotechnology advancements. Meanwhile, China's trajectory is even more pronounced, with forecasts showing an 11.8% CAGR, reaching $252.4 billion by 2030, underscored by its dynamic market activities and burgeoning investments.
Other geographic regions are not left behind in this growth sprint. Japan and Canada are expected to climb the growth ladder with 5.4% and 7% CAGRs, respectively. Europe joins the growth bandwagon, led by Germany at an anticipated 6.5% CAGR. The research sheds light on strategic market positions, with a focus on competitor market shares and regional market presence, from Strong to Trivial.
- DNA Sequencing and Fermentation Markets: Critical sectors with high CAGRs contributing to growth
- U.S. Market Outlook: Strong foundational USD valuation and ongoing innovation
- China's Growth Acceleration: Remarkable expansion rate within biotech sector
The top-tier competitors shaping the biotech playing field are also featured in this comprehensive analysis, highlighting the strategic moves of industry leaders.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 222 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $568.9 Billion |
| Forecasted Market Value (USD) by 2030 | $1100 Billion |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Global |
A selection of companies mentioned in this report includes
- Agilent Technologies, Inc.
- BD Biosciences
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Illumina, Inc.
- Merck KgaA
- PerkinElmer, Inc.
- QIAGEN GmbH
- Thermo Fisher Scientific, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/z5zaz7
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
